跳至主要内容
临床试验/NCT07646483
NCT07646483尚未招募不适用

A Multicenter, Randomized, Double-Blind, Active-Controlled, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of Intra-Articular Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis

PharmaResearch Co.,Ltd0 个研究点目标入组 180 人开始时间: 2026年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
180

研究概览

简要总结

This clinical trial aims to evaluate and compare the efficacy and safety of Conjuran® and Hyruan in patients with knee osteoarthritis following first and second cycle (repeat) administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥40 years
  • Knee osteoarthritis diagnosed according to ACR criteria
  • KL grade I-III
  • Weight-bearing pain VAS ≥40 mm
  • Written informed consent

排除标准

  • Inflammatory or secondary arthritis
  • Recent treatment in the target knee
  • Significant uncontrolled medical conditions
  • Hypersensitivity to study device components
  • Pregnancy or breastfeeding
  • Participation in another clinical trial

研究者

发起方
PharmaResearch Co.,Ltd
申办方类型
Industry
责任方
Sponsor

相似试验